Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells
Section snippets
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
This work was supported by the grants from the Natural Science Foundation of Jiangsu province (No. BK20171179 and BK20181151), the Six Talent Peaks Project in Jiangsu Province (Grant No. 2017-YY-039), Jiangsu Provincial 333 High-level Talents Cultivation Project (BRA201927), the Postgraduate Research & Practice Innovation Program of Jiangsu Province (No. KYCX20_2506) and Jiangsu Training Programs of Innovation and Entrepreneurship for Undergraduates (Grant No. 201810313083X). We thank to Public
References (27)
- et al.
ABC transporters as mediators of drug resistance and contributors to cancer cell biology
Drug Resist Updat
(2016) - et al.
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: an update
Drug Resist Updat
(2020) - et al.
Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance
Eur J Med Chem
(2016) - et al.
Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity
Eur J Pharmacol
(2020) - et al.
Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy
Toxicol Appl Pharm
(2017) - et al.
Enantioselective synthesis, DFT calculations, and preliminary antineoplastic activity of dibenzo 1-azaspiro [4.5] decanes on drug-resistant leukemias
J Org Chem
(2019) - et al.
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
Blood
(2013) - et al.
A novel harmine derivative, N-(4-(hydroxycarbamoyl) benzyl)-1-(4-methoxyphenyl)-9H-pyrido [3, 4-b] indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects
Eur J Pharmacol
(2018) - et al.
Modulating ROS to overcome multidrug resistance in cancer
Drug Resist Update
(2018) - et al.
Synthesis and biological evaluation of bifendate derivatives bearing acrylamide moiety as novel antioxidant agents
Eur J Med Chem
(2019)
Synthesis and assessment of phenylacrylamide derivatives as potential anti-oxidant and anti-inflammatory agents
Eur J Med Chem
(2019)
Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell
Biochem Pharmacol
(2018)
β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma
Eur J Med Chem
(2019)
Cited by (7)
Discovery of novel itaconimide-based derivatives as potent HDAC inhibitors for the efficient treatment of prostate cancer
2024, European Journal of Medicinal ChemistryDesign and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response
2023, Journal of Medicinal ChemistryTripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use
2023, Journal of Enzyme Inhibition and Medicinal ChemistryTargeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
2022, International Journal of Molecular Sciences
- 1
These two authors contributed equally to this work.
© 2020 Elsevier Ltd. All rights reserved.